Signaling 2013: From structure to function

The scientific program for Signalling 2013 - from Structure to Function, is designed to represent the cutting edge of modern signal transduction research. By including diverse, yet interrelated, topics this keystone meeting will demonstrate how cell signalling continues to underpin key advances in biological and medical research in the 21st century.


Second messengers
REDOX signalling
Small molecule inhibitors
Lipid and protein kinases
Ion channels

Reviews by the speakers, based on their presentations at this major international meeting, will be published exclusively in Biochemical Society Transactions (Volume 42, part 1).

The scientific program for 'Signalling 2013 - from Structure to Function' encompasses a broad range of signalling topics with the common theme of structure/function relationships, ranging from macromolecules to small molecule therapeutics. The meeting schedule represents the cutting edge of modern signal transduction research and includes structure/function analysis within the emerging field of REDOX signalling, in humans and bacteria, the development of small molecule inhibitors for the treatment of inflammation and cancer, advances in ubiquitin research and recent key insights into structure/function relationships of ion channels and protein/lipid kinases. These diverse, yet interrelated topics will demonstrate how Cell Signalling continues to underpin key advances in biological and medical research. The aim of this multi-focus approach is to assist participants in finding areas of commonality within diverse signalling scenarios and will therefore represent the major diary event for the majority of laboratories with an interest in signal transduction; thereby fostering a sense of community and continuity within the field.

Given the importance of signalling pathways as principal targets for modern medicines we anticipate an equal level of interest from the pharmaceutical industry, as was the case with our flagship Signalling meeting in 2011. Signalling 2013 will therefore reflect the current multi-disciplinary nature of modern signal transduction research and highlight the importance of structure/function analysis in the development of modern medicines.
+ show speakers and program

Kristopher Clark (University of Dundee, United Kingdom)
Colin Taylor (University of Cambridge, United Kingdom)
David Komander (MRC Laboratory of Molecular Biology, United Kingdom)
Golnaz Vahedi (National Institute of Arthritis and Musculoskeletal and Skin Diseases, U.S.A.)
Helen Mott (University of Cambridge, United Kingdom)
Jane Endicott (Newcastle University, United Kingdom)
Neil Bulleid (University of Glasgow, United Kingdom)
Neil Perkins (Newcastle University Medical School, United Kingdom)
Nicola Curtin (Newcastle University, United Kingdom)
Peter Parker (CRUK London Research Institute, United Kingdom)
Yvonne Jones (University of Oxford, United Kingdom)

17 Jul - 19 Jul 2013
United Kingdom
meeting website